Webinar: Ensuring source material consistency and continuity for commercialization of advanced therapies

2020 CGTI Webinar Thumbnail

A critical aspect to ensuring patient access to cell & gene therapies, and continued growth of the industry, is having a proper awareness for managing source material quality and supply chain continuity.

Speakers Dominic Clarke of HemaCare, Amy Shaw of Beam Therapeutics, and Christopher Good of Biocair will discuss: 

  • The importance of defining source material requirements for translation of allogeneic advanced therapies.
  • The benefits of a reliable & recallable donor network for consistent source material access.
  • The critical requirements for obtaining GMP-compliant source materials necessary for commercial manufacture.
  • How to navigate the critical aspects in handling, monitoring, and delivering temperature sensitive source materials.
  • The importance of early planning, coordination, and communication with all stakeholders.

Simply complete the form to watch this free webinar!